The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population
<div><p><strong>BACKGROUND:</strong> Fingolimod (FTY-720) has shown efficacy in relapsing multiple sclerosis (MS), while some side effects of this drug have been recognized that the most important is cardiovascular side effects. The aim of this study was to evaluate the cardiovascular side effects o...
محفوظ في:
| المؤلفون الرئيسيون: | , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Vesnu Publications
2017-03-01
|
| سلاسل: | ARYA Atherosclerosis |
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://arya.mui.ac.ir/index.php/arya/article/view/1348 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|